期刊文献+

16例心脏瓣膜置换术后患者死亡原因分析 被引量:5

Analysis of reasons leading to death of 16 cases underwent cardiac valvular replacement
下载PDF
导出
摘要 目的分析心脏瓣膜置换术后患者围手术期死亡原因,探讨降低死亡率的措施。方法对1998年10月至2012年3月我科施行的心脏瓣膜置换术后16例围手术期死亡患者的死亡原因进行回顾性总结和分析。结果术中死亡4例,包括低心排出量综合征(LCOS)不能停体外循环2例,主动脉口血1例,早期左心室破裂1例。其他12例死于术后3h至27d,其中LCOS4例、迟发型左心室破裂2例、肾功能衰竭2例、呼吸功能衰竭2例、甲亢危像1例。结论术前进行有效的针对性治疗,术中尽可能缩短手术及体外循环时间,减少手术意外,积极、有效地预防和处理并发症的发生,是降低心脏瓣膜置换术后死亡率的关健。 Objective To analyze reasons leading to perioperative deaths of patients underwent cardiac valvular replacement and explore managements to decrease mortality. Methods We retrospectively analyzed and reviewed 16 patients died intra or after valvular replacement between October 1998 and March 2012 in our depart- ment. Results There were 4 patients died intraoperatively, including 2 cases with low cardiac output syndrome (LCOS) and not weaning off cardiopulmonary bypass, 1 case with aortic hemorrhage, and 1 case with early rup- ture of left ventricle. Another 12 patients died 3 hours to 27 days after valvular replacement, including 4 cases with LCOS, 2 cases with delayed rupture of left ventricle, 2 cases with renal failure, 2 cases with respiratory fail- ure, and 1 case with hyperthyroidism crisis. Conclusion It is key factors to decrease mortality of valvular re- placement to aim directly at improving cardiac and respiratory function effectively before operation, shorten dura- tion of operation and cardiopulmonary bypass as far as possible, avoid accidents intraoperatively, and to prevent and manage complications effectively and actively.
出处 《中国心血管病研究》 CAS 2013年第1期27-29,共3页 Chinese Journal of Cardiovascular Research
关键词 心脏瓣膜置换术 围手术期 死亡原因 Heart valve replacement Perioperative period Cause of death
  • 相关文献

参考文献8

二级参考文献92

共引文献42

同被引文献85

  • 1许建屏,史艺,葛翼鹏,潘世伟,钱向阳,柳枫.瓣膜手术后呼吸功能衰竭的危险因素分析[J].中华胸心血管外科杂志,2006,22(4):217-219. 被引量:28
  • 2段亮,肖明第,袁忠祥,杨迪成,胡振雷,王利民.同期行冠状动脉旁路移植及心瓣膜置换术80例[J].中国胸心血管外科临床杂志,2007,14(3):169-172. 被引量:16
  • 3Borger MA, Yan TM, Rao V, et al. Reoperative mitral valve re- placement: importance of preservation of the subvalvular appara- tus. Ann Thorac Surg, 2002, 74: 1482-1487.
  • 4Del CC, Sherman JR. Tricuspid valve replacement: results com- paring mechanical and biological prostheses. Ann Thorac Surg, 2000, 69: 1295.
  • 5Akins CW, Buckley M J, Daggett WM, et al. Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg,1998, 65 : 1545-1551.
  • 6Raanani E, David TE, Dellgren G, et al. Redo aortic root re- placement: experience with 31 patients. Ann horac Surg,2001, 71 : 1460-1463.
  • 7Kuduvalli M,Grayson AD,Au J. A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement[J].{H}European Journal of Cardio-thoracic Surgery,2007,(04):607-613.
  • 8Florath I,Rosendahl UP,Mortasawi A. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement[J].{H}ANNALS OF THORACIC SURGERY,2003,(01):75-83.
  • 9Astor BC,Kaczmarek RG,Hefflin B. Mortality after aortic valve replacement:results from a nationally representative database[J].{H}ANNALS OF THORACIC SURGERY,2000,(06):1939-1945.
  • 10Eggebrecht H,Schǎfer U,Treede H. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves[J].JACC Cardiovasc I nterv,2011,(11):1218-1227.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部